FILTER CONTENT

Filtered (69)
Filters
Post Date
Company Names
Show (69)
Cancel

Research

  • 7investing logo next to the Veeva Systems logo.
    By Published On: February 17, 2025

    Veeva’s Slow-and-Steady Results Are Winning the Software Race; Shares Still a “Buy”

    Veeva's third quarter 2025 results demonstrated that its growth is continuing to slow, [...]

  • By Published On: November 19, 2024

    November 2024 Conviction Rating Review

  • By Published On: October 30, 2024

    Supermicro’s Accountant Resigns; Downgrading to “Hold”

  • By Published On: October 21, 2024

    October 2024 Conviction Rating Review

  • By Published On: September 19, 2024

    September 2024 Conviction Rating Review

  • By Published On: August 19, 2024

    August 2024 Conviction Rating Review

  • By Published On: June 13, 2024

    Sell Enphase Energy

  • By Published On: March 21, 2024

    Sell Vaxxinity

  • 7investing logo next to the BeiGene logo.
    By Published On: February 13, 2024

    BeiGene: Extreme Risk with Extreme Potential Reward. Shares are a “Buy”

  • By Published On: December 18, 2023

    7investing’s 2023 Year in Review: An Updated Look at All of Our Stock Picks

  • By Published On: December 11, 2023

    Enphase Faces Short-Term Headwinds; We’re Downgrading it to “Hold”

  • 7investing logo next to the Illumina logo.
    By Published On: September 13, 2023

    Illumina: New Leadership and a New Strategy; Changing our Conviction to “Hold”

  • 7investing logo next to the Guardant Health logo.
    By Published On: August 2, 2023

    Guardant and Illumina are Burying the Hatchet and Extending Their Partnership

  • By Published On: July 28, 2023

    Set (En-)phasers to Stun

  • By Published On: July 27, 2023

    ServiceNow Keeps Delivering Results Despite Macro Headwinds

  • By Published On: July 13, 2023

    Is Grail Good or Bad for Illumina?